ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

15.10
Delayed Data
As of 4:00pm ET
 +0.82 / +5.74%
Today’s Change
12.77
Today|||52-Week Range
41.20
-49.85%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close14.28
Today’s open14.28
Day’s range14.19 - 15.17
Volume1,654,927
Average volume (3 months)2,591,040
Market cap$1.8B
Data as of 4:00pm ET, 09/19/2018

Growth & Valuation

Earnings growth (last year)-0.85%
Earnings growth (this year)+11.69%
Earnings growth (next 5 years)+22.47%
Revenue growth (last year)+620.68%
P/E ratioNM
Price/Sales29.56
Price/Book5.30

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+1.05+2.25%
PAHCPhibro Animal Health...-1.10-2.51%
MRTXMirati Therapeutics ...+2.80+5.14%
ENTAEnanta Pharmaceutica...+1.16+1.28%
Data as of 4:00pm ET, 09/19/2018

Financials

Next reporting dateNovember 7, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$124.9M
Annual profit (last year)-$289.4M
Net profit margin-231.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Executive VP, Chief Financial &
Accounting Officer
Todd S. Young
Corporate headquarters
San Diego, California

Forecasts